Article ID Journal Published Year Pages File Type
16245 Current Opinion in Biotechnology 2010 7 Pages PDF
Abstract

Marine cyanobacteria are a rich source of complex bioactive secondary metabolites which derive from mixed biosynthetic pathways. Recently, several marine cyanobacterial natural products have garnered much attention due to their intriguing structures and exciting anti-proliferative or cancer cell toxic activities. Several other recently discovered secondary metabolites exhibit insightful neurotoxic activities whereas others are showing pronounced anti-inflammatory activity. A number of anti-infective compounds displaying activity against neglected diseases have also been identified, which include viridamides A and B, gallinamide A, dragonamide E, and the almiramides.

Related Topics
Physical Sciences and Engineering Chemical Engineering Bioengineering
Authors
, , ,